Wedelolactone Attenuates Pulmonary Fibrosis Partly Through Activating AMPK and Regulating Raf-MAPKs Signaling PathwayJinyu Yang(China Pharmaceutical University), Renshi Li(China Pharmaceutical University)Frontiers in PharmacologyMarch 5, 201910.3389/fphar.2019.00151Cited by 62SaveCiteExport RISWatch citationsRelated PapersBaicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis via the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway|Frontiers in Pharmacology|2020|52Alpha-Mangostin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice Partly Through Activating Adenosine 5′-Monophosphate-Activated Protein Kinase|Frontiers in Pharmacology|2019|31